515 related articles for article (PubMed ID: 32194864)
1. Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment
Yang J; Shi Z; Liu R; Wu Y; Zhang X
Theranostics; 2020; 10(7):3223-3239. PubMed ID: 32194864
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology.
Rezaei V; Rabiee A; Khademi F
J Chemother; 2020 May; 32(3):107-117. PubMed ID: 31984871
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery approaches for the treatment of glioblastoma multiforme.
Fakhoury M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.
Ung N; Yang I
J Neurooncol; 2015 Jul; 123(3):473-81. PubMed ID: 26070553
[TBL] [Abstract][Full Text] [Related]
5. Use of nanoparticles for drug delivery in glioblastoma multiforme.
Jain KK
Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
[TBL] [Abstract][Full Text] [Related]
7. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies.
Liu D; Dai X; Ye L; Wang H; Qian H; Cheng H; Wang X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1838. PubMed ID: 35959642
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma.
Verma J; Lal S; Van Noorden CJ
Int J Nanomedicine; 2014; 9():2863-77. PubMed ID: 24959075
[TBL] [Abstract][Full Text] [Related]
10. Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme.
Bhaskaran M; Devegowda VG; Gupta VK; Shivachar A; Bhosale RR; Arunachalam M; Vaishnavi T
ACS Chem Neurosci; 2020 Oct; 11(19):2962-2977. PubMed ID: 32945654
[TBL] [Abstract][Full Text] [Related]
11. Role of nanobiotechnology in the personalized management of glioblastoma multiforme.
Jain KK
Nanomedicine (Lond); 2011 Apr; 6(3):411-4. PubMed ID: 21542679
[No Abstract] [Full Text] [Related]
12. Nanoparticles Mediated the Diagnosis and Therapy of Glioblastoma: Bypass or Cross the Blood-Brain Barrier.
Song X; Qian H; Yu Y
Small; 2023 Nov; 19(45):e2302613. PubMed ID: 37415556
[TBL] [Abstract][Full Text] [Related]
13. Evolution of Magnetic Hyperthermia for Glioblastoma Multiforme Therapy.
Gupta R; Sharma D
ACS Chem Neurosci; 2019 Mar; 10(3):1157-1172. PubMed ID: 30715851
[TBL] [Abstract][Full Text] [Related]
14. From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.
Zygogianni A; Protopapa M; Kougioumtzopoulou A; Simopoulou F; Nikoloudi S; Kouloulias V
Clin Transl Oncol; 2018 Aug; 20(8):989-1003. PubMed ID: 29335830
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme.
Cabrera AR; Cuneo KC; Vredenburgh JJ; Sampson JH; Kirkpatrick JP
J Natl Compr Canc Netw; 2012 Jun; 10(6):695-9. PubMed ID: 22679114
[TBL] [Abstract][Full Text] [Related]
16. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
Gutkin A; Cohen ZR; Peer D
Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
[TBL] [Abstract][Full Text] [Related]
17. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
[TBL] [Abstract][Full Text] [Related]
18. Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features.
Kim HJ; Kim DY
Molecules; 2020 Oct; 25(20):. PubMed ID: 33053763
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.
Li R; Wang H; Liang Q; Chen L; Ren J
Biomater Sci; 2022 Feb; 10(4):892-908. PubMed ID: 34989724
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of different treatment strategies in elderly patients with glioblastoma: An evidence map of randomized controlled trials.
Ma W; Sheng X; Li G; Wei Q; Zhou Z; Qiu X
Crit Rev Oncol Hematol; 2022 May; 173():103645. PubMed ID: 35227898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
